...
首页> 外文期刊>Journal of the advanced practitioner in oncology >Optimal Collaborative Management of Patients With Esophagogastric Cancers
【24h】

Optimal Collaborative Management of Patients With Esophagogastric Cancers

机译:食管胃癌患者的最佳协同管理

获取原文
获取原文并翻译 | 示例
           

摘要

Bsophageal and gastric cancers account for 2.6% of all malignancies. Survival has improved over the past 3 decades, but it still remains only about 30% at 5 years for those with this type of cancer."Clearly, treatments that go beyond surgery alone are indicated," said David Ilson, MD, PhD, of Memorial Sloan Kettering Cancer Center, New York, who discussed this malignancy at JADPRO Live, along with Steve Malangone, MSN, FNP-C, AOCNP", of the University of Arizona Cancer Center, Tucson.
机译:食道癌和胃癌占所有恶性肿瘤的2.6%。在过去30年中,患者的生存率有所提高,但这类癌症患者在5年后的生存率仍然只有30%左右。MD亚利桑那大学癌症中心的纽约斯隆-凯特林癌症中心的David Ilson博士说:“很明显,仅仅是外科手术之外的治疗就已经表明了。”他在JADPRO Lead上与Steve Malangone、MSN、FNP-C、AOCPNP一起讨论了恶性肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号